SCHEMBL5135913

SCHEMBL5135913

CC(=O)Oc1cc[c]c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
CYP3A4 P08684 2/20 0.46
KDM4E B2RXH2 4/20 0.42
ACHE P22303 2/20 0.42
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
POLB P06746 2/20 0.39
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
GLA P06280 2/20 0.39
GAA P10253 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 3/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TTR P02766 1/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FLT3 P36888 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3820131 0.87 KDM4E (0.33) LMNACYP3A4KDM4ETDP1MAPT
SCHEMBL1451590 0.83 LMNA (0.47) LMNACYP3A4KDM4EACHEPOLB
SCHEMBL3820731 0.81 MEN1 (0.52) MEN1KMT2A
SCHEMBL28084471 0.78 LMNA (0.46) LMNACYP3A4KDM4EACHEPOLB
SCHEMBL4777768 0.77 ALDH1A1 (0.39) LMNAKDM4EPOLBGLAGAA
SCHEMBL7083421 0.76 LMNA (0.44) LMNACYP3A4KDM4EACHEPOLB
SCHEMBL21681471 0.76 CYP4F2 (0.50) LMNACYP3A4KDM4EACHECYP4F2
SCHEMBL919169 0.75
SCHEMBL4242 0.74
SCHEMBL10605638 0.74 LMNA (0.42) LMNACYP3A4KDM4EACHEPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781303-A4 METHODS AND REAGENTS FOR THE TREATMENT OF METABOLIC DISORDERS COMBINATORX INC (US) 2008-07-02 EP disclosed
EP-1781303-A1 METHODS AND REAGENTS FOR THE TREATMENT OF METABOLIC DISORDERS CombinatoRx, Incorporated (US) 2007-05-09 EP disclosed
WO-2006004803-A1 METHODS AND REAGENTS FOR THE TREATMENT OF METABOLIC DISORDERS COMBINATORX, INCORPORATED (US) 2006-01-12 WO disclosed
US-4755513-A Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1988-07-05 US disclosed